The document discusses the role of artificial intelligence (AI) in the pharmaceutical sector, encompassing its evolution, advantages, disadvantages, and applications in drug discovery and healthcare. It highlights key milestones in AI development, including the introduction of neural networks, machine learning, and deep learning. Additionally, it outlines how AI technologies are streamlining drug discovery processes, enhancing medical diagnostics, and improving patient care in healthcare systems.